GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
94.51
+6.40 (7.26%)
At close: Mar 9, 2026, 4:00 PM EDT
93.67
-0.84 (-0.89%)
After-hours: Mar 9, 2026, 5:56 PM EDT
Company Description
GeneDx Holdings Corp., a genomics company, provides genetic testing services.
The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp.
| Country | United States |
| Founded | 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 1,300 |
| CEO | Katherine Stueland |
Contact Details
Address: North Tower, 6th Floor Stamford, Connecticut 06902 United States | |
| Phone | 888 729 1206 |
| Website | genedx.com |
Stock Details
| Ticker Symbol | WGS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001818331 |
| CUSIP Number | 81663L200 |
| ISIN Number | US81663L2007 |
| Employer ID | 85-1966622 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Katherine A. Stueland | President, Chief Executive Officer and Director |
| Dr. Bryan M. Dechairo Ph.D. | Chief Operating Officer |
| Heidi C. Chen J.D. | Chief Legal Officer |
| Jami Biliboaca | Head of People Strategy |
| Melanie Duquette | Chief Growth Officer |
| Dr. Martin G. Reese Ph.D. | President of Fabric Genomics |
| Lisa Gurry | Chief Business Officer |
| Dr. Mimi Lee M.D., Ph.D. | Chief of Precision Medicine Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 2, 2026 | 8-K | Current Report |
| Feb 23, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 23, 2026 | 10-K | Annual Report |
| Feb 23, 2026 | 8-K | Current Report |
| Feb 2, 2026 | 144 | Filing |
| Jan 29, 2026 | 144 | Filing |
| Jan 29, 2026 | 144 | Filing |
| Jan 12, 2026 | 8-K | Current Report |
| Nov 24, 2025 | 144 | Filing |
| Nov 12, 2025 | SCHEDULE 13G/A | Filing |